CA-PSMF
Patient Safety Movement Foundation (PSMF) – a global non-profit dedicated to unifying those involved in the healthcare ecosystem, identifying challenges that are causing patient deaths, and creating actionable solutions to mitigate them – is pleased to announce the appointment of its new chairman of the board of directors – Michael A.E. Ramsay, MD, FRCA. It also reaffirms its commitment to patient health and safety with updates to its mission, vision and values; and reestablishes its goal of achieving ZERO preventable patient deaths by 2030.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200310005733/en/
As one of PSMF’s longest-standing board members, serving since 2013, Dr. Ramsay has been an advocate for patient safety in the anesthesia world since the 1980’s and embodies the values and principles set forth by the foundation. He is a renowned medical professional and the current president of the Baylor Scott & White Research Institute, where he spearheads clinically relevant research efforts. Well-known for the development and implementation of the Ramsay Sedation Scale – a tool that has been adopted globally, designed for interpreting the depth of sedation for patients in the critical care unit; he also serves as chairman of the Department of Anesthesiology and Pain Management at Baylor University Medical Center in Dallas, Texas.
“The Patient Safety Movement has achieved tremendous momentum in the eight years since its inception,” said Joe Kiani, founder and prior chairman of the board of the Patient Safety Movement Foundation. “Kindling this important movement has been an enormous part of my life’s work, and I am thrilled to pass the torch to Dr. Ramsay to carry our shared vision forward into the future with passion and enthusiasm.”
To date, the foundation has accomplished:
- Saving 366,353 lives since 2013
- Securing 48 countries with committed hospitals
- Securing 54 countries with partner groups (i.e. hospitals, open data pledge, other partners)
- Securing 4,793 total committed hospitals
- Securing 92 total pledges
- Securing 94 total partners
- Saving a total of 93,276 lives in 2019 alone
While the foundation did not achieve its prior goal of hitting zero preventable patient deaths by 2020, it renews the pledge with a new target goal of 2030.
“It is a great honor to be appointed chairman of the board of directors of the Patient Safety Movement Foundation,” states Dr. Ramsay. “Lives are being saved and patient harm is being prevented. We share monumentally important goals and have taken great leaps forward thus far; and I truly look forward to building upon the successes to date to achieve ZERO preventable patient deaths by 2030.” Dr. Ramsay has written his first “Letter from the Chairman” which is published monthly on the PSMF’s website. To read his first letter, visit: https://patientsafetymovement.org/newsletters/march-2020-issue-ii/letter-from-the-chairman-march-2020 .
The Patient Safety Movement Foundation will continue to provide tools, resources and guidelines aimed at educating healthcare providers, industry professionals, patients and families, to achieve its vision of a future that diminishes and ultimately eliminates preventable patient deaths. It will do so by:
- Prioritizing safety with patients at the center.
- Promoting dignity, compassion and respect in healthcare.
- Aligning everyone who influences or is touched by healthcare.
- Promoting transparency.
- Realigning incentives to achieve safer care.
- Informing caregivers, patients and families about patient safety.
- Identifying the preventable causes of patient harm and death, and then create and freely share actionable solutions (Actionable Patient Safety Solutions) to mitigate them.
- Driving the implementation of Actionable Patient Safety Solutions (APSS).
-
Asking healthcare technology companies to share data to create a Patient Data Superhighway.
To learn more about Patient Safety Movement Foundation, visit https://patientsafetymovement.org/ .
ABOUT PATIENT SAFETY MOVEMENT FOUNDATION: More than 200,000 people die every year in U.S. hospitals and 4.8 million worldwide in ways that could have been prevented. The Patient Safety Movement Foundation (PSMF) is a global non-profit working toward a future that diminishes and ultimately eliminates preventable patient deaths by offering tools, resources and guidelines aimed at educating healthcare providers, industry professionals, patients and families. It was established through the support of the Masimo Foundation for Ethics, Innovation and Competition in Healthcare to achieve the goal of ZERO preventable patient deaths. Achieving this goal requires a collaborative effort from all stakeholders, including patients, healthcare providers, medical technology companies, government, employers and private payers. The Patient Safety Movement Foundation is dedicated to unifying those involved in the healthcare ecosystem, identifying challenges that are causing patient deaths, creating actionable solutions to mitigate them, and partnering with hospitals who are committed to implementing its specific, high-impact solutions to meet patient safety challenges called Actionable Patient Safety Solutions (APSS) . The organization also encourages medical technology companies to share the data their products are purchased for, and asks hospitals to make commitments to implement Actionable Patient Safety Solutions. To learn more, visit patientsafetymovement.org.
Editor’s Note: To schedule interviews with the experts from Patient Safety Movement Foundation, please email jennifer@beyondfifteen.com or call 949.733.8679.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200310005733/en/
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Quectel Announces Industry First 5G-Advanced 3GPP R18 Automotive-Grade Cellular Module, Delivering Unmatched Performance and Reliability2.1.2026 18:00:00 CET | Press release
Quectel Wireless Solutions, an end-to-end global IoT solutions provider, today announces the launch of the world's first 5G-advanced (5G-A) automotive-grade cellular module, the AR588MA, establishing it as the industry's highest-performing and most reliable wireless communication product for vehicles. Based on MediaTek's latest-generation MT2739 platform, the AR588MA supports 5G-A communication technology and is the world's first to comply with the 3GPP R18 standard protocol. The module also features both NB-NTN and NR-NTN satellite communication capabilities, supports Dual SIM Dual Active (DSDA) technology, offering improved stability and reliability on cellular connections and includes intelligent driving scenario recognition. Designed in compliance with the AEC-Q104 Grade 2 automotive standard, it delivers faster, more stable connectivity and reliable security for in-vehicle communication and benefiting the on-roof applications like smart antenna for automotive with higher temperatu
Interactive Brokers’ Individual and Hedge Fund Clients Outperformed the S&P 500 on Average in 20252.1.2026 16:00:00 CET | Press release
Lower costs, global market access, and efficient execution contributed to stronger client outcomes. Interactive Brokers (Nasdaq: IBKR), an automated global electronic broker, today announced that its clients outperformed the S&P 500 Index in 2025, reflecting the benefits of cost efficiency, execution quality, and broad access to global markets. In 2025, Interactive Brokers’ individual clients achieved an average return of 19.20%, compared with the 17.9% return of the S&P 500 Index. During the same period, Interactive Brokers’ hedge fund clients achieved an average return of 28.91%, outperforming the index by approximately 11 percentage points. These results demonstrate how Interactive Brokers helps enhance client returns across the investment lifecycle. Global market access enables clients to allocate capital across various regions and asset classes, while lower trading and financing costs, along with efficient execution, help IBKR investors retain more of their returns over time. “Inv
Aeromexico Repeats as Most On-Time Global Airline; Qatar Airways Claims Platinum Award2.1.2026 11:00:00 CET | Press release
Virgin Atlantic wins new award as most improved airline for on-time performance Aeromexico maintained a 90.02% on-time performance to claim the world's most on-time global airline title for the second consecutive year, according to Cirium's 2025 On-Time Performance Review released today. The Mexican carrier becomes only the second airline to achieve consecutive global wins since Cirium launched the program in 2009, operating 188,859 flights across 23 countries while maintaining industry-leading schedule reliability. Aeromexico Holds Global Lead; Regional Champions Crowned Aeromexico secured the global airline title with 90.02% on-time performance, holding off strong competition from Saudia in second place with 86.53% and SAS with 86.09% in third. The margin between first and third place was 3.93 percentage points, reflecting the strong performance of Aeromexico in 2025. Regional winners included: North America: Delta Air Lines won for the fifth consecutive year with 80.90% on-time perf
Samsung Bioepis Begins Commercialization of BYOOVIZ®, Biosimilar to Lucentis (Ranibizumab), in Europe2.1.2026 08:00:00 CET | Press release
Samsung Bioepis completes full transfer of commercial rights from Biogen back to Samsung Bioepis for BYOOVIZ®BYOOVIZ becomes the fourth biosimilar directly commercialized by Samsung Bioepis in Europe, following EPYSQLI® (eculizumab), OBODENCE® (denosumab), and XBRYK® (denosumab)Pre-filled syringe (PFS) presentation to become available in Europe in the second quarter of 2026 Samsung Bioepis Co., Ltd. today announced that the company has begun direct commercialization of BYOOVIZ®, a biosimilar to Lucentis1 (ranibizumab), in Europe. Samsung Bioepis has been working to ensure seamless transfer of commercial rights from Biogen back to Samsung Bioepis, and BYOOVIZ will now be available as a Samsung Bioepis brand across multiple European countries. “This is a significant milestone for Samsung Bioepis as the company continues to strengthen its presence in Europe by expanding its portfolio of directly commercialized products. Leveraging the past three years of experience with EPYSQLI (eculizuma
Cessna Citation Ascend Enters Into Service, Redefining Performance and Cabin Experience in the Midsize Business Jet Market31.12.2025 15:00:00 CET | Press release
The Cessna Citation Ascend achieved a major milestone as the first retail customer took delivery of the midsize business jet on Tuesday, December 30, marking the aircraft’s entry into service. Announced in 2023 the aircraft boasts an entirely new cockpit, improved performance and a luxurious flat floor cabin. The Citation Ascend received type certification from the Federal Aviation Administration (FAA) in November 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251231586042/en/ Cessna Citation Ascend enters into service, redefining performance and cabin experience in the midsize business jet market. (Photo credit: Textron Aviation) The Cessna Citation Ascend is designed and manufactured by Textron Aviation Inc., a Textron Inc. (NYSE: TXT) company. “The first Citation Ascend delivery underscores Textron Aviation’s commitment to redefining the midsize segment with an aircraft that blends innovation, efficiency and unmatch
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
